Real-world effectiveness and safety of tolvaptan in liver cirrhosis patients with hepatic edema: results from a post-marketing surveillance study (START study)
ConclusionsThe results suggest that tolvaptan was effective and well-tolerated in liver cirrhosis patients with hepatic edema. In the real-world clinical setting, tolvaptan provides a useful option for the treatment of hepatic edema.
Source: Journal of Gastroenterology - Category: Gastroenterology Source Type: research
More News: Cirrhosis | Drugs & Pharmacology | Gastroenterology | Japan Health | Liver | Sodium | Study | Urology & Nephrology